Nu Skin Enterprises (NYSE:NUS) Issues FY 2026 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 0.800-1.200 for the period, compared to the consensus estimate of 1.420. The company issued revenue guidance of $1.4 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion. Nu Skin Enterprises also updated its Q1 2026 guidance to 0.100-0.200 EPS.

Nu Skin Enterprises Price Performance

NYSE NUS traded up $0.04 during trading hours on Thursday, hitting $10.21. The company had a trading volume of 490,137 shares, compared to its average volume of 466,491. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.45 and a current ratio of 2.15. The firm has a market capitalization of $497.88 million, a price-to-earnings ratio of 4.68 and a beta of 1.01. Nu Skin Enterprises has a 52 week low of $5.32 and a 52 week high of $14.62. The firm has a 50 day simple moving average of $10.36 and a 200 day simple moving average of $10.65.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Thursday, February 12th. The company reported $0.29 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.01). Nu Skin Enterprises had a return on equity of 9.15% and a net margin of 7.02%.The firm had revenue of $370.32 million during the quarter, compared to analysts’ expectations of $382.70 million. Nu Skin Enterprises has set its FY 2026 guidance at 0.800-1.200 EPS and its Q1 2026 guidance at 0.100-0.200 EPS. Equities research analysts expect that Nu Skin Enterprises will post 1.05 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on NUS shares. Wall Street Zen cut shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 15th. Weiss Ratings restated a “hold (c)” rating on shares of Nu Skin Enterprises in a research report on Thursday, January 22nd. Finally, Zacks Research upgraded Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a report on Friday, January 30th. Two analysts have rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of “Hold”.

Institutional Trading of Nu Skin Enterprises

Institutional investors have recently made changes to their positions in the stock. Wexford Capital LP purchased a new position in Nu Skin Enterprises during the third quarter valued at $40,000. Banque Cantonale Vaudoise purchased a new position in Nu Skin Enterprises during the 3rd quarter valued at about $57,000. Tower Research Capital LLC TRC boosted its stake in Nu Skin Enterprises by 107.4% during the second quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock worth $40,000 after acquiring an additional 2,614 shares in the last quarter. Quadrant Capital Group LLC bought a new stake in Nu Skin Enterprises during the third quarter worth about $85,000. Finally, National Bank of Canada FI grew its holdings in Nu Skin Enterprises by 1,040,200.0% in the third quarter. National Bank of Canada FI now owns 10,403 shares of the company’s stock worth $127,000 after purchasing an additional 10,402 shares during the period. Hedge funds and other institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.